BACHEM N/ CH1176493729 /
2024-04-19 5:30:11 PM | Chg. +0.10 | Volume | Bid5:40:00 PM | Ask5:40:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
78.65CHF | +0.13% | 55,724 Turnover: 4.35 mill. |
76.00Bid Size: 2,000 | 82.50Ask Size: 250 | 5.9 bill.CHF | 0.95% | 52.43 |
GlobeNewswire
2021-03-16
Bachem chooses iland and Veeam to spearhead data continuity and cloud backup transition
GlobeNewswire
2020-05-14
Relief Therapeutics and NeuroRx Announce Final Manufacturing Validation of RLF-100 for Phase 2b/3 Cl...
GlobeNewswire
2020-05-04
Generex Biotechnology Initiates Peptide Manufacturing for Ii-Key- SARS-CoV-2 Peptide Vaccine Against...
GlobeNewswire
2020-04-28
Generex Subsidiary NuGenerex Immuno-Oncology Announces Publication of Positive Results of the AE37 P...
GlobeNewswire
2019-10-04
Vaccine Contract Manufacturing Market, 2030 - Market is Anticipated to Generate Revenues Worth USD 1...
GlobeNewswire
2019-03-26
Global Pharmaceutical Contract Manufacturing Market 2018-2025 - Patent Expiration Of Small Molecules...
GlobeNewswire
2018-09-13
Global Pharmaceutical Spray Drying Market Report 2018: Focus on APIs, Inhalables, Injectables, Biolo...
GlobeNewswire
2018-09-07
Global Pharmaceutical Contract Manufacturing Market, 2018-2028 - Use of Big Data and Advanced Analyt...
GlobeNewswire
2018-07-20
Opportunity Outlook for the Global Peptide Synthesis Market (2018-2023): Opportunities in Emerging M...
GlobeNewswire
2018-01-24
Global High Potency Active Pharmaceutical Ingredients (HPAPI) Market 2017-2023: $27.29 Billion Marke...
GlobeNewswire
2018-01-10
6 Key Projections on Future of Peptide and Heparin Market for Forecast Period 2017 – 2026